Viemed Healthcare (VMD) Price to Sales (2019 - 2026)

Viemed Healthcare (VMD) has reported Price to Sales for 8 consecutive years, with 5.56 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Price to Sales rose 28.1% year-over-year to 5.56; the trailing twelve-month figure through Jun 2026 stood at 1.44 (up 26.72% YoY), and the FY2025 full-year result was 1.05, down 25.32% from the prior year.
• Price to Sales grew to 5.56 in Q2 2026 per VMD's latest filing, from 4.71 in the prior quarter.
• Across five years, Price to Sales topped out at 9.35 in Q1 2023 and bottomed at 3.59 in Q3 2025.
• Historically, Price to Sales has averaged 5.79 across 5 years, with a median of 5.4 in 2023.
• The sharpest annual moves came in 2022 and 2023: Price to Sales sank 56.96% in 2022, then surged 54.08% in 2023.
• Over 5 years, Price to Sales stood at 7.67 in 2022, then declined by 22.32% to 5.96 in 2023, then dropped by 13.2% to 5.17 in 2024, then declined by 28.29% to 3.71 in 2025, then jumped by 49.94% to 5.56 in 2026.
• According to Business Quant data, Price to Sales over the past three periods registered 5.56, 4.71, and 3.71 for Q2 2026, Q1 2026, and Q4 2025 respectively.